Jubilant Pharmova Limited (NSE: JUBLPHARMA)
India
· Delayed Price · Currency is INR 1,097.40
+32.70 (3.07%)
Dec 24, 2024, 3:30 PM IST
Jubilant Pharmova Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 69,197 | 67,029 | 62,817 | 61,302 | 60,985 | 59,758 | Upgrade
|
| Revenue Growth (YoY) | 6.49% | 6.71% | 2.47% | 0.52% | 2.05% | -34.41% | Upgrade
|
| Cost of Revenue | 23,904 | 23,513 | 20,816 | 14,880 | 15,360 | 14,552 | Upgrade
|
| Gross Profit | 45,293 | 43,516 | 42,001 | 46,422 | 45,625 | 45,206 | Upgrade
|
| Selling, General & Admin | 23,250 | 22,873 | 22,151 | 20,739 | 19,440 | 18,843 | Upgrade
|
| Other Operating Expenses | 11,698 | 11,593 | 12,011 | 13,621 | 11,509 | 10,881 | Upgrade
|
| Operating Expenses | 38,725 | 38,285 | 38,252 | 38,023 | 34,183 | 32,819 | Upgrade
|
| Operating Income | 6,568 | 5,231 | 3,749 | 8,398 | 11,443 | 12,387 | Upgrade
|
| Interest Expense | -2,604 | -2,564 | -1,686 | -1,382 | -1,734 | -1,884 | Upgrade
|
| Interest & Investment Income | 261 | 261 | 98 | 24.51 | 80.97 | 189.46 | Upgrade
|
| Earnings From Equity Investments | 434 | 511 | 123 | -99.83 | 112.52 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -42 | -42 | 172 | -464.53 | -644.67 | 143.91 | Upgrade
|
| Other Non Operating Income (Expenses) | 167 | -5 | -83 | 14.45 | -40.22 | -72 | Upgrade
|
| EBT Excluding Unusual Items | 4,784 | 3,392 | 2,373 | 6,491 | 9,218 | 10,764 | Upgrade
|
| Gain (Loss) on Sale of Investments | 2 | 2 | -50 | 1.47 | 28.23 | -2.37 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | -27 | -33.7 | -66.91 | - | Upgrade
|
| Asset Writedown | -1,689 | -1,689 | -1,450 | -153.83 | -255.81 | -417.03 | Upgrade
|
| Other Unusual Items | 3,817 | - | -568 | - | -212.31 | -216.14 | Upgrade
|
| Pretax Income | 6,914 | 1,705 | 278 | 6,304 | 8,711 | 10,129 | Upgrade
|
| Income Tax Expense | 1,025 | 978 | 927 | 2,174 | 2,972 | 3,351 | Upgrade
|
| Earnings From Continuing Operations | 5,889 | 727 | -649 | 4,130 | 5,739 | 6,778 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | 2,618 | 2,205 | Upgrade
|
| Net Income to Company | 5,889 | 727 | -649 | 4,130 | 8,356 | 8,982 | Upgrade
|
| Minority Interest in Earnings | 42 | 44 | 39 | 9.2 | 2.58 | 0.03 | Upgrade
|
| Net Income | 5,931 | 771 | -610 | 4,139 | 8,359 | 8,982 | Upgrade
|
| Net Income to Common | 5,931 | 771 | -610 | 4,139 | 8,359 | 8,982 | Upgrade
|
| Net Income Growth | - | - | - | -50.48% | -6.94% | 56.36% | Upgrade
|
| Shares Outstanding (Basic) | 158 | 159 | 159 | 159 | 159 | 159 | Upgrade
|
| Shares Outstanding (Diluted) | 159 | 159 | 159 | 159 | 159 | 159 | Upgrade
|
| Shares Change (YoY) | -0.03% | -0.18% | -0.02% | -0.06% | -0.01% | 2.19% | Upgrade
|
| EPS (Basic) | 37.45 | 4.86 | -3.83 | 26.01 | 52.48 | 56.39 | Upgrade
|
| EPS (Diluted) | 37.33 | 4.86 | -3.83 | 26.00 | 52.48 | 56.39 | Upgrade
|
| EPS Growth | - | - | - | -50.46% | -6.93% | 53.00% | Upgrade
|
| Free Cash Flow | -2,744 | 736 | -1,538 | 2,376 | 12,568 | 9,688 | Upgrade
|
| Free Cash Flow Per Share | -17.27 | 4.63 | -9.66 | 14.92 | 78.91 | 60.82 | Upgrade
|
| Dividend Per Share | - | 5.000 | 5.000 | 5.000 | 5.000 | 5.000 | Upgrade
|
| Dividend Growth | - | 0% | 0% | 0% | 0% | 11.11% | Upgrade
|
| Gross Margin | 65.46% | 64.92% | 66.86% | 75.73% | 74.81% | 75.65% | Upgrade
|
| Operating Margin | 9.49% | 7.80% | 5.97% | 13.70% | 18.76% | 20.73% | Upgrade
|
| Profit Margin | 8.57% | 1.15% | -0.97% | 6.75% | 13.71% | 15.03% | Upgrade
|
| Free Cash Flow Margin | -3.97% | 1.10% | -2.45% | 3.88% | 20.61% | 16.21% | Upgrade
|
| EBITDA | 9,228 | 7,933 | 6,463 | 10,663 | 14,676 | 15,482 | Upgrade
|
| EBITDA Margin | 13.34% | 11.84% | 10.29% | 17.39% | 24.07% | 25.91% | Upgrade
|
| D&A For EBITDA | 2,660 | 2,702 | 2,714 | 2,264 | 3,234 | 3,095 | Upgrade
|
| EBIT | 6,568 | 5,231 | 3,749 | 8,398 | 11,443 | 12,387 | Upgrade
|
| EBIT Margin | 9.49% | 7.80% | 5.97% | 13.70% | 18.76% | 20.73% | Upgrade
|
| Effective Tax Rate | 14.82% | 57.36% | 333.45% | 34.49% | 34.12% | 33.08% | Upgrade
|
| Revenue as Reported | 70,056 | 67,716 | 63,200 | 61,415 | 61,162 | 60,132 | Upgrade
|
| Advertising Expenses | - | 664 | 413 | 259.84 | 161.77 | 353.73 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.